164 related articles for article (PubMed ID: 29293675)
1. Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study.
Dogan MV; Grumbach IM; Michaelson JJ; Philibert RA
PLoS One; 2018; 13(1):e0190549. PubMed ID: 29293675
[TBL] [Abstract][Full Text] [Related]
2. External validation of integrated genetic-epigenetic biomarkers for predicting incident coronary heart disease.
Dogan MV; Knight S; Dogan TK; Knowlton KU; Philibert R
Epigenomics; 2021 Jul; 13(14):1095-1112. PubMed ID: 34148365
[TBL] [Abstract][Full Text] [Related]
3. Blood-Based Biomarkers for Predicting the Risk for Five-Year Incident Coronary Heart Disease in the Framingham Heart Study via Machine Learning.
Dogan MV; Beach SRH; Simons RL; Lendasse A; Penaluna B; Philibert RA
Genes (Basel); 2018 Dec; 9(12):. PubMed ID: 30567402
[TBL] [Abstract][Full Text] [Related]
4. Identification of DNA methylation-regulated genes as potential biomarkers for coronary heart disease via machine learning in the Framingham Heart Study.
Zhang X; Wang C; He D; Cheng Y; Yu L; Qi D; Li B; Zheng F
Clin Epigenetics; 2022 Sep; 14(1):122. PubMed ID: 36180886
[TBL] [Abstract][Full Text] [Related]
5. Accurate Prediction of Coronary Heart Disease for Patients With Hypertension From Electronic Health Records With Big Data and Machine-Learning Methods: Model Development and Performance Evaluation.
Du Z; Yang Y; Zheng J; Li Q; Lin D; Li Y; Fan J; Cheng W; Chen XH; Cai Y
JMIR Med Inform; 2020 Jul; 8(7):e17257. PubMed ID: 32628616
[TBL] [Abstract][Full Text] [Related]
6. Validation of an Integrated Genetic-Epigenetic Test for the Assessment of Coronary Heart Disease.
Philibert R; Dogan TK; Knight S; Ahmad F; Lau S; Miles G; Knowlton KU; Dogan MV
J Am Heart Assoc; 2023 Nov; 12(22):e030934. PubMed ID: 37982274
[TBL] [Abstract][Full Text] [Related]
7. Association between DNA methylation and coronary heart disease or other atherosclerotic events: A systematic review.
Fernández-Sanlés A; Sayols-Baixeras S; Subirana I; Degano IR; Elosua R
Atherosclerosis; 2017 Aug; 263():325-333. PubMed ID: 28577936
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation signatures of incident coronary heart disease: findings from epigenome-wide association studies.
Xia Y; Brewer A; Bell JT
Clin Epigenetics; 2021 Oct; 13(1):186. PubMed ID: 34627379
[TBL] [Abstract][Full Text] [Related]
9. Evidence of association of circulating epigenetic-sensitive biomarkers with suspected coronary heart disease evaluated by Cardiac Computed Tomography.
Infante T; Forte E; Schiano C; Punzo B; Cademartiri F; Cavaliere C; Salvatore M; Napoli C
PLoS One; 2019; 14(1):e0210909. PubMed ID: 30673762
[TBL] [Abstract][Full Text] [Related]
10. The Reversion of the Epigenetic Signature of Coronary Heart Disease in Response to Smoking Cessation.
Philibert R; Moody J; Philibert W; Dogan MV; Hoffman EA
Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372412
[TBL] [Abstract][Full Text] [Related]
11. Characterization and machine learning prediction of allele-specific DNA methylation.
He J; Sun MA; Wang Z; Wang Q; Li Q; Xie H
Genomics; 2015 Dec; 106(6):331-9. PubMed ID: 26407641
[TBL] [Abstract][Full Text] [Related]
12. APOE hypermethylation is significantly associated with coronary heart disease in males.
Ji H; Zhou C; Pan R; Han L; Chen W; Xu X; Huang Y; Huang T; Zou Y; Duan S
Gene; 2019 Mar; 689():84-89. PubMed ID: 30576806
[TBL] [Abstract][Full Text] [Related]
13. Precision epigenetics provides a scalable pathway for improving coronary heart disease care globally.
Broyles D; Philibert R
Epigenomics; 2023 Aug; 15(16):805-818. PubMed ID: 37702023
[TBL] [Abstract][Full Text] [Related]
14. Multilocus genetic risk scores for coronary heart disease prediction.
Ganna A; Magnusson PK; Pedersen NL; de Faire U; Reilly M; Arnlöv J; Sundström J; Hamsten A; Ingelsson E
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2267-72. PubMed ID: 23685553
[TBL] [Abstract][Full Text] [Related]
15. Genomic prediction of coronary heart disease.
Abraham G; Havulinna AS; Bhalala OG; Byars SG; De Livera AM; Yetukuri L; Tikkanen E; Perola M; Schunkert H; Sijbrands EJ; Palotie A; Samani NJ; Salomaa V; Ripatti S; Inouye M
Eur Heart J; 2016 Nov; 37(43):3267-3278. PubMed ID: 27655226
[TBL] [Abstract][Full Text] [Related]
16. Chronological age prediction based on DNA methylation: Massive parallel sequencing and random forest regression.
Naue J; Hoefsloot HCJ; Mook ORF; Rijlaarsdam-Hoekstra L; van der Zwalm MCH; Henneman P; Kloosterman AD; Verschure PJ
Forensic Sci Int Genet; 2017 Nov; 31():19-28. PubMed ID: 28841467
[TBL] [Abstract][Full Text] [Related]
17. Comparison of genetic risk prediction models to improve prediction of coronary heart disease in two large cohorts of the MONICA/KORA study.
Bauer A; Zierer A; Gieger C; Büyüközkan M; Müller-Nurasyid M; Grallert H; Meisinger C; Strauch K; Prokisch H; Roden M; Peters A; Krumsiek J; Herder C; Koenig W; Thorand B; Huth C
Genet Epidemiol; 2021 Sep; 45(6):633-650. PubMed ID: 34082474
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of DNA methylation profile of HLA-G gene and imaging in coronary heart disease: Pilot study.
Schiano C; Benincasa G; Infante T; Franzese M; Castaldo R; Fiorito C; Mansueto G; Grimaldi V; Della Valle G; Fatone G; Soricelli A; Nicoletti GF; Ruocco A; Mauro C; Salvatore M; Napoli C
PLoS One; 2020; 15(8):e0236951. PubMed ID: 32790754
[TBL] [Abstract][Full Text] [Related]
19. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease.
Li L; Pan Y; Dai L; Liu B; Zhang D
Med Sci Monit; 2016 Jan; 22():31-40. PubMed ID: 26726843
[TBL] [Abstract][Full Text] [Related]
20. Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study.
Nishimura K; Okamura T; Watanabe M; Nakai M; Takegami M; Higashiyama A; Kokubo Y; Okayama A; Miyamoto Y
J Atheroscler Thromb; 2014; 21(8):784-98. PubMed ID: 24671110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
